STEP I: Patients must not have active, uncontrolled infection Patient must not have an active uncontrolled infection Any active acute or chronic or uncontrolled infection Patients with active, uncontrolled infection Unstable systemic disease or active uncontrolled infection Active uncontrolled infection; Active infection requiring systemic treatment or any uncontrolled infection CTCAE grade 2 uncontrolled with antibiotics Active, uncontrolled infection Active clinically serious and uncontrolled infection Active uncontrolled infection Active uncontrolled infection Uncontrolled active infection Uncontrolled active infection Active or uncontrolled infection Have an active, uncontrolled infection Any uncontrolled active systemic infection Active uncontrolled infection. Uncontrolled active infection Active and uncontrolled infection at time of transplantation Active uncontrolled infection Active uncontrolled infection Active uncontrolled infection Active uncontrolled infection Uncontrolled active infection; Patients with an active or uncontrolled infection. Active pneumonitis or uncontrolled infection Patient must not have an active, uncontrolled infection Patients with documented active, uncontrolled infection at the time of study entry Patients who have an active or uncontrolled infection are excluded Active uncontrolled infection Subject has active, uncontrolled infection Active uncontrolled infection Subject has an active uncontrolled infection. Patients must not have active, uncontrolled infection Subject has active, uncontrolled infection Have evidence of uncontrolled, active infection <7 days prior to administration of study medication. Active or uncontrolled infection Uncontrolled active infection Uncontrolled active infection Patients with active or uncontrolled systemic infection. Free of active uncontrolled infection at the time of study entry Active, uncontrolled infection Active uncontrolled infection Any uncontrolled active systemic infection. Uncontrolled active infection within one week prior to first dose Uncontrolled medical disease(s) or active, uncontrolled infection Active uncontrolled serious infection or sepsis at study enrollment Subject has an active uncontrolled infection. Active uncontrolled serious infection or sepsis at study enrollment Uncontrolled active infection Active uncontrolled infection No active uncontrolled infection Active, uncontrolled systemic infection Patients who have uncontrolled active infection Active uncontrolled infection Active uncontrolled infection Uncontrolled active infection or illness Patients with an active or uncontrolled infection. Subjects with an active uncontrolled infection. Active major systemic or local uncontrolled infection Known active uncontrolled systemic infection Uncontrolled active infection Have a significant uncontrolled infection active infection Have significant, uncontrolled active infection Uncontrolled active infection Patients with active, uncontrolled infection Serious uncontrolled active infection Active uncontrolled infection Has an active, uncontrolled infection; Active or uncontrolled infection Active uncontrolled infection at time of enrollment or documented fungal infection within 3 months Patients with active or uncontrolled systemic infection. Active, uncontrolled infection Active uncontrolled infection Subject has an active uncontrolled infection Active uncontrolled infection; Active uncontrolled opportunistic infection Any active or uncontrolled infection Active, uncontrolled infection Active or uncontrolled infection Active and uncontrolled infection at the time of transplantation Any uncontrolled active systemic infection Patient is known to have an uncontrolled active systemic infection Active, uncontrolled infection Active uncontrolled infection Active/uncontrolled infection Active, uncontrolled infection Active, uncontrolled infection Active and uncontrolled infection Evidence of uncontrolled active infection Serious or uncontrolled co-existent non-malignant disease, including active and uncontrolled infection Any concurrent medical condition or disease (e.g., uncontrolled active hypertension, uncontrolled active diabetes, active systemic infection, etc.) that is likely to interfere with study procedures. Any uncontrolled active systemic infection